Italom TRB 100 Tablet contains Itraconazole 100 mg and Terbinafine 250 mg, a dual-action antifungal formulation designed for systemic and superficial fungal infections. Itraconazole works by inhibiting ergosterol synthesis in fungal cell membranes, while Terbinafine disrupts fungal squalene epoxidase, providing complementary mechanisms for potent antifungal efficacy.
Clinically, Italom TRB 100 Tablet is indicated for dermatophytosis, onychomycosis, candidiasis, and other fungal infections where single-agent therapy may be insufficient. Its dual mechanism ensures faster fungal eradication, reduced recurrence rates, and improved clinical outcomes in both adults and adolescents.
The tablet formulation ensures precise dosing, consistent bioavailability, and reliable therapeutic effect, making it suitable for hospitals, dermatology clinics, infectious disease centers, and specialty pharmacies that require high-quality antifungal supply. Its oral administration allows for convenient dosing and improved patient adherence.
Italom TRB 100 Tablet also contributes to comprehensive management of fungal infections, supporting both symptomatic relief and long-term fungal control. It provides healthcare providers with a safe, effective, and evidence-based antifungal therapy for challenging or persistent fungal conditions.